Coverart for item
The Resource Preserving the Promise : Improving the Culture of Biotech Investment

Preserving the Promise : Improving the Culture of Biotech Investment

Label
Preserving the Promise : Improving the Culture of Biotech Investment
Title
Preserving the Promise
Title remainder
Improving the Culture of Biotech Investment
Creator
Contributor
Subject
Language
eng
Cataloging source
MiAaPQ
Literary form
non fiction
Nature of contents
dictionaries
Preserving the Promise : Improving the Culture of Biotech Investment
Label
Preserving the Promise : Improving the Culture of Biotech Investment
Link
http://libproxy.rpi.edu/login?url=https://ebookcentral.proquest.com/lib/rpi/detail.action?docID=4713584
Publication
Copyright
Related Contributor
Related Location
Related Agents
Related Authorities
Related Subjects
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
  • Front Cover -- Preserving the Promise -- Copyright Page -- Contents -- Preface -- Acknowledgments -- Innovation Meets the Translation Gap -- 1 Stop the Madness and Cure Something -- 2 Into the Valley of Death -- References -- 3 Clinical Promise {u2260} Investment Practice -- References -- 4 Velcade, a Biotech Success Story -- References -- 5 Biotechnology and the Future of Pharma -- References -- 6 Why Pharma Should Care About the Valley of Death -- References -- 7 Porter's Five Forces and the Market for Angel Capital -- A Paradigm for Analysis -- The Prospect of Total Loss -- References -- 8 Out of the Frying Pan: The Fire's Not So Great Either -- Juggling Interest, Support, Commitment, and IP -- A Fulcrum of Tension -- The Special Case of Conflict of Interest -- References -- 9 Getting to Australia -- Reaching the Limits -- References -- Translation Gap 1: Universities Don't Make What Companies Need -- 10 When Is an Experiment Ready for the Valley of Death? -- Why Not Simply License the Technology to a Big Healthcare Company? -- Collaboration and Conflict -- References -- 11 Unintended Consequences of Applying for a Patent -- The Dollars Begin to Flow -- The Real Costs of a Patent Application -- References -- 12 What if It Doesn't Actually Work? -- References -- 13 Building a Better Mousetrap -- References -- Translation Gap 2: Good Innovation Is Not Always a Good Investment -- 14 Due Diligence and Angel Incentives -- How Angels Decide -- Due Diligence-An Overview -- Due Diligence-Getting Specific -- Exogenous Factors -- Unmet Clinical or Professional Need -- Size and Growth of the Addressable Market -- Adaptability of the Technology or Product to Clinical Practice -- Potential for Sustainable Competitive Advantage -- References -- 15 What Is Value? -- Attractiveness and Plausibility of the Technology
  • Likelihood that Clinical Proof of Concept is Achievable -- Challenges of the Regulatory Environment -- Attractiveness of the Business Model -- Financial Viability -- Exit Strategy -- Human Resources and Contingency Planning -- Reflections on Due Diligence -- So Where is Big Pharma/Big Biotech on All This? A Breakdown in Value -- References -- 16 Angels at the Crux of Invention -- Bad Stuff Gets Funded and Good Stuff Dies -- The Uncertainty of Scientific Due Diligence -- Investing to the Next Money -- References -- 17 Investment: A Nuanced Decision -- References -- 18 Ready for a Long-Term Relationship With a Science Experiment? -- Due Diligence Versus De-Risking -- Financing the Biotechnology Start-up -- Buying and Selling in the VoD -- The Perils of Convertible Debt -- References -- 19 Investing in Hockey Sticks -- The Hockey Stick-A Matter of Inflection -- Milestone Driven Investments -- The Perfect Deal -- ROI Versus Innovation -- References -- 20 Harps for Angels -- Consideration of the Macro Environment -- Regional, Economic, and Cultural Influences -- References -- 21 Connecting Innovation to Investment -- Reducing the Risk of Scientific Failure -- Rewarding the Long Game -- References -- Translation Gap 3: Technology Transfer Wastes Money and Innovation -- 22 Mitigating Supplier Power -- How It's Not Supposed to Work -- The Real Costs of Supplier Power -- Reducing the Costs of Technology Transfer -- Assignment of an Invention: What If We Give It Away? -- An Ounce of Prevention -- References -- 23 Preventing Speeding by Closing the Road -- Aligning Incentives -- References -- 24 Breaking Old Habits -- Company Building as a Focus of Technology Transfer -- Building an Innovation Community -- What is the Least We Can Do? -- The Minimal Commercialization Unit -- References -- Epilogue -- 25 Epilogue: Why We Do This -- References -- Index
  • Back Cover
http://library.link/vocab/cover_art
https://contentcafe2.btol.com/ContentCafe/Jacket.aspx?Return=1&Type=S&Value=9780128092095&userID=ebsco-test&password=ebsco-test
Dimensions
unknown
http://library.link/vocab/discovery_link
{'f': 'http://opac.lib.rpi.edu/record=b4367881'}
Extent
1 online resource (277 pages)
Form of item
online
Isbn
9780128092095
Media category
computer
Media MARC source
rdamedia
Media type code
c
Sound
unknown sound
Specific material designation
remote

Library Locations

    • Folsom LibraryBorrow it
      110 8th St, Troy, NY, 12180, US
      42.729766 -73.682577
Processing Feedback ...